TLR9 and hepatocellular carcinoma: Recent studies indicated that stimulation of TLR9 with CpG-ODN enhanced apoptosis in murine or human tumor cells [27,28], but ODN M362 promotes cell proliferation and survival in human hepatocellular carcinomas [10].